Nuvasive 

€36.8
3
+€0+0% Thursday 19:50

統計

當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
1.92B
本益比
-107.61
股息殖利率
-
股息
-

財報

8May預期
Q2 2021
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0.44
0.49
0.55
0.6
預期EPS
不適用
實際EPS
不適用

財務

3.22%利潤率
有盈利
2017
2018
2019
2020
2021
2022
1.14B營收
36.91M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 NK8.F 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. it provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology and its intraoperative neuromonitoring services and support; and specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone. The company also offers reline fixation system that facilitates the preservation and restoration of patient alignment; integrated global alignment platform consisting of Bendini spinal rod bending system that assists with manual rod manipulation for spinal fixation; Lessray that is an image enhancement platform designed to reduce radiation exposure in the operating room, as well as Pulse, which integrates multiple enabling technologies to enhance workflow, reduce variability, and increase the reproducibility of surgical outcomes; and various biologics that are used to aid in the spinal fusion or bone healing process. In addition, it provides MAGEC, a spinal bracing and distraction system, Precice limb lengthening system, and various other products for treating specialized orthopedic procedures; onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries; and cervical artificial disc technology for cervical total disc replacement procedures. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Show more...
執行長
Mr. J. Christopher Barry
員工
2700
國家
美國
ISIN
US6707041058
WKN
000A0CAYR

上市

0 Comments

分享你的想法

FAQ

Nuvasive 今天的股價是多少?
NK8.F 目前價格為 €36.8 EUR,過去 24 小時上漲了 +0%。在圖表上更密切關注 Nuvasive 股價表現。
Nuvasive 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Nuvasive 的股票以代號 NK8.F 進行交易。
Nuvasive 的市值是多少?
今天 Nuvasive 的市值為 1.92B
Nuvasive 去年的營收是多少?
Nuvasive 去年的營收為 1.14BEUR。
Nuvasive 去年的淨利是多少?
NK8.F 去年的淨收益為 36.91MEUR。
Nuvasive 有多少名員工?
截至 April 29, 2026,公司共有 2,700 名員工。
Nuvasive 位於哪個產業?
Nuvasive從事於Health & Wellness產業。
Nuvasive 何時完成拆股?
Nuvasive 最近沒有進行任何拆股。
Nuvasive 的總部在哪裡?
Nuvasive 的總部位於 美國 的 San Diego。